5 Healthcare Stocks to Buy According to Billionaire Noam Gottesman’s GLG Partners

2. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Noam Gottesman’s Stake Value: $169 million

Percentage of Noam Gottesman’s 13F Portfolio: 0.59%

Number of Hedge Fund Holders: 60

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is an American biotechnology company that focuses on a narrow segment. It offers products for Cystic Fibrosis which is a genetic disease that affects several organs such as the lungs and the stomach. The company is involved in researching treatments and it also sells medicines and cell correctors.

As the second quarter came to an end, GLG Partners held 840,124 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares that were worth $169 million and represented 0.59% of the company’s stock.

In a second quarter 2021 letter, Harding Loevner had the following to say:

“Among the largest detractors from relative performance (includes) Vertex Pharmaceuticals. Vertex fell after the company halted development of one of its drug candidates undergoing Phase 2 trials. The failure leaving some investors wondering if Vertex’s much-heralded research capabilities might not extend beyond its core franchise in cystic fibrosis, a view we respectfully reject.”